- Home
- PHGE vs STFS Comparison
PHGE vs STFS Comparison
Compare PHGE & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- STFS
- Stock Information
- Founded
- PHGE 2015
- STFS 2015
- Country
- PHGE Israel
- STFS China
- Employees
- PHGE N/A
- STFS N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- STFS
- Sector
- PHGE Health Care
- STFS
- Exchange
- PHGE Nasdaq
- STFS NYSE
- Market Cap
- PHGE 14.6M
- STFS 16.7M
- IPO Year
- PHGE N/A
- STFS 2024
- Fundamental
- Price
- PHGE $0.50
- STFS $1.29
- Analyst Decision
- PHGE Strong Buy
- STFS
- Analyst Count
- PHGE 2
- STFS 0
- Target Price
- PHGE $20.00
- STFS N/A
- AVG Volume (30 Days)
- PHGE 85.8K
- STFS 367.4K
- Earning Date
- PHGE 05-15-2025
- STFS 02-14-2025
- Dividend Yield
- PHGE N/A
- STFS N/A
- EPS Growth
- PHGE N/A
- STFS N/A
- EPS
- PHGE N/A
- STFS 0.01
- Revenue
- PHGE N/A
- STFS $16,754,197.00
- Revenue This Year
- PHGE N/A
- STFS N/A
- Revenue Next Year
- PHGE N/A
- STFS N/A
- P/E Ratio
- PHGE N/A
- STFS $144.14
- Revenue Growth
- PHGE N/A
- STFS 75.86
- 52 Week Low
- PHGE $0.45
- STFS $0.80
- 52 Week High
- PHGE $4.90
- STFS $17.91
- Technical
- Relative Strength Index (RSI)
- PHGE 40.96
- STFS N/A
- Support Level
- PHGE $0.45
- STFS N/A
- Resistance Level
- PHGE $0.52
- STFS N/A
- Average True Range (ATR)
- PHGE 0.04
- STFS 0.00
- MACD
- PHGE -0.00
- STFS 0.00
- Stochastic Oscillator
- PHGE 39.31
- STFS 0.00
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About STFS STAR FASHION CULTURE HOLDINGS LIMITED
Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.